Showing 1 - 2 of 2
Potential Impact of Takeda’s Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results
Published on 24/05/2021
» •Takeda’s dengue vaccine candidate (TAK-003) prevented 83.6% of hospitalizations and 62.0% of dengue illness overall, with no identified important safety risks through three years following vaccination in ongoing pivotal Phase 3 TIDES trial • Regulatory filings for TAK-003 progressing in European Union and in many dengue-endemic countries; filing in United States planned for later this year • Dengue is the fastest-spreading mosquito-borne viral disease with an estimated 390 million cases and 500,000 hospitalizations per year globally, with limited options for prevention
Permanent revolutionary
Life, Yvonne Bohwongprasert, Published on 09/11/2018
» When your father happens to be Ernesto "Che" Guevara, the Argentine Marxist revolutionary who was an engine of the Cuban Revolution, you learn early in life to be emotionally strong, grounded and defiant -- proud of your ideology, regardless of how it may be viewed by the rest of the world.